Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 5, 2005, Pages 645-654

  Copping, Vanessa M S ^a   Barelle, Caroline J ^a   Hube, Bernhard ^b   Gow, Neil A R ^a   Brown, Alistair J P ^a   Odds, Frank C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Amphotericin B; Caspofungin; Fluconazole; Flucytosine; Itraconazole; Virulence; Virulence genes

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ASPARTIC PROTEINASE; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MESSENGER RNA; MICONAZOLE; PYRROLE DERIVATIVE; SECRETED ASPARTIC PROTEINASE 2; SECRETED ASPARTIC PROTEINASE 9; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE; FUNGAL GENE; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS ISOLATION; GENE EXPRESSION; HUMAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIFUNGAL AGENTS; ASPARTIC ENDOPEPTIDASES; AZOLES; CANDIDA ALBICANS; FLUCYTOSINE; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GREEN FLUORESCENT PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES, CYCLIC; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS;

EID: 18844462400     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki088     Document Type: Article

References (28)

1. Fekete-Forgacs, K., Kis, B., Nagy, G. et al. (1999). Effect of fluconazole on the growth and adhesion of Candida albicans in the presence of antineoplastic agents. Journal of Basic Microbiology 39, 305-10.
2. Darwazeh, A. M. G., Lamey, P. J., Lewis, M. A. O. et al. (1991). Systemic fluconazole therapy and in vitro adhesion of [i Candida albicans to human buccal epithelial cells. Journal of Oral Pathology and Medicine 20, 17-19.
3. Nosanchuk, J. D., Cleare, W., Franzot, S. P. et al. (1999). Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations. Antimicrobial Agents and Chemotherapy 43, 233-9.
4. Xhonneaux, B., Jansen, T., Borgers, M. et al. (1992). Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs. Journal of Antimicrobial Chemotherapy 30, 181-8.
5. Brummer, E. & Stevens, D. A. (1996). Synergy of human neutrophils with fluconazole in killing Candida species. Mycopathologia 134, 115-20.
6. Brummer, E., Bhagavathula, P. R., Hanson, L. H. et al. (1992). Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis. Antimicrobial Agents and Chemotherapy 36, 2487-92.
7. Garcha, U. K., Brummer, E. & Stevens, D. A. (1996). Synergy of fluconazole with macrophages for antifungal activity against Candida albicans. Mycopathologia 132, 123-8.
8. Rogers, P. D., Stiles, J. K., Chapman, S. W. et al. (2000). Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1. Journal of Infectious Diseases 182, 1280-3.
9. Reyes, E., Cardona, J., Prieto, A. et al. (2000). Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells. Journal of Infectious Diseases 181, 2003-10.
10. Willis, A. M., Coulter, W. A., Fulton, C. R. et al. (2001). The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 91, 317-21.
11. Lass-Florl, C., Ledochowski, M., Fuchs, D. et al. (2003). Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro. FEMS Immunology and Medical Microbiology 35, 11-15.
12. Wu, T., Wright, K., Hurst, S. F. et al. (2000). Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates, following growth in subinhibitory concentrations of fluconazole. Antimicrobial Agents and Chemotherapy 44, 1200-8.
13. Hube, B., Monod, M., Schofield, D. A. et al. (1994). Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Molecular Microbiology 14, 87-99.
14. Ripeau, J. S., Aumont, F., Belhumeur, P. et al. (2002). Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro. Antimicrobial Agents and Chemotherapy 46, 3096-100.
15. Kurtz, M. B., Abruzzo, G., Bartizal, K. et al. (1996). Characterization of echinocardin-resistant mutants of Candida albicans - genetic, biochemical, and virulence, studies. Infection and Immunity 64, 3244-51.
16. Hube, B., Sanglard, D., Odds, F. C. et al. (1997). Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infection and Immunity 65, 3529-38.
17. Sanglard, D., Hube, B., Monod, M. et al. (1997). A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infection and Immunity 65, 3539-46.
18. Murad, A. M. A., Lee, P. R., Broadbent, I. D. et al. (2000). Clp10, an efficient and convenient integrating vector for Candida albicans. Yeast 16, 325-7.
19. Brand, A., MacCallum, D. M., Brown, A. J. P. et al. (2004). Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS1 locus. Molecular Microbiology 3, 900-9.
20. Albrecht, A., Felk, A., Pichova, I., et al. (2004). SAP9 and SAP10 of Candida albicans: localisation, function and their relevance for virulence. In Program and Abstracts of the ASM Conference on Candida and Candidiasis, Austin, TX, 2004. Abstract 217(A), p. 121. American Society for Microbiology, Washington, DC, USA.
21. Barelle, C. J., Manson, C. L., MacCallum, D. M. et al. (2004). GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast 21, 333-40.
22. Hayes, A., Zhang, N., Wu, J. et al. (2002). Hybridization array technology coupled with chemostat culture: tools to interrogate gene expression in Saccharomyces cerevisiae. Methods 26, 281-90.
23. Lorenz, M. C. & Fink, G. R. (2002). Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryotic Cell 1, 657-62.
24. Odds, F. C., Brown, A. J. P. & Gow, N. A. R. (2003). Antifungal agents: mechanisms of action. Trends in Microbiology 11, 272-9.
25. Hube, B. & Naglik, J. (2001). Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147, 1997-2005.
26. Naglik, J. R., Challacombe, S. J. & Hube, B. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiology and Molecular Biology Reviews 67, 400-28.
27. White, T. C. & Agabian, N. (1995). Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. Journal of Bacteriology 177, 5215-21.
28. De Backer, M. D., Ilyina, T., Ma, X. J. et al. (2001). Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrobial Agents and Chemotherapy 45, 1660-70.